ASPN binds to CD44 in pancreatic cancer cells and activates the CD44/AKT/ERK-NF-kB signaling axis, which lead to EMT induction and increased migration and invasion [65] (Table 1). Here, NFKB1 is linked to pancreatic neoplasm.